Topbuild Corp buy BiotechBee
Start price
08.08.23
/
70%
€268.00
Target price
31.01.26
€330.00
Performance (%)
-12.69%
End price
01.10.23
€234.00
Summary
This prediction ended on 01.10.23 with a price of €234.00. The prediction for Topbuild Corp disappointed with a performance of -12.69%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Topbuild Corp | 1.105% | 1.105% | 11.585% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
According to BiotechBee what are the pros and cons of Topbuild Corp for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Topbuild Corp diskutieren
Buy mit Kursziel 330,0